The echocardiographic Tei-index reflects early myocardial damage induced by anthracyclines in patients with hematological malignancies

Heart and Vessels

Volumn 22, Issue 6, 2007, Pages 393-397

  Senju, Norihiko ^a   Ikeda, Satoshi ^a   Koga, Seiji ^a   Miyahara, Yoshiyuki ^a   Tsukasaki, Kunihiro ^a   Tomonaga, Masao ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anthracycline; Cardiotoxicity; Echocardiography; Left ventricular ejection fraction; Tei index

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOTOXICITY; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DIASTOLE; DOPPLER ECHOCARDIOGRAPHY; DOSE RESPONSE; DRUG DOSE INCREASE; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEMATOLOGIC MALIGNANCY; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SYSTOLE; TEI INDEX; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADOLESCENT; ADULT; AGED; ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; DOXORUBICIN; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART DISEASES; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; STROKE VOLUME;

EID: 36749051819     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-007-0985-x     Document Type: Article

References (36)

1. GN Hortobagyi 1997 Anthracyclines in the treatment of cancer. An overview Drugs 54 Suppl 4 1-7 9361955 1:CAS:528:DyaK2sXntlygu7w%3D
2. P Jacobs L Wood 2005 Clonogenic growth patterns correlate with chemotherapy response in acute myeloid leukaemia Hematology 10 321-326 16085545 10.1080/10245330500141622 1:CAS:528:DC%2BD2MXpvVShsbw%3D
3. CA Schiffer EJ Lee 1989 Approaches to the therapy of relapsed acute myeloid leukemia Oncology 3 23-27 2519195 1:STN:280:By2D3s%2FovFc%3D
4. G Laurent JP Jaffrezou 2001 Signaling pathways activated by daunorubicin Blood 98 913-924 11493433 10.1182/blood.V98.4.913 1:CAS:528:DC%2BD3MXmtFeisrk%3D
5. D Iarussi P Indolfi M Galderisi E Bossone 2000 Cardiac toxicity after anthracycline chemotherapy in childhood Herz 25 676-688 11141677 10.1007/ PL00001982 1:STN:280:DC%2BD3M7it1Wiuw%3D%3D
6. M Hauser BS Gibson N Wilson 2001 Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography Eur J Pediatr 160 607-610 11686505 10.1007/s004310100830 1:STN:280:DC%2BD3MnhtFOisA%3D%3D
7. I Moyssakis N Moschos F Triposkiadis Y Hallaq N Pantazopoulos A Aessopos M Kolettis 2005 Left ventricular end-systolic stress/diameter relation as a contractility index and as a predictor of survival. Independence of preload after normalization for end-diastolic diameter Heart Vessels 20 191-198 16160899 10.1007/s00380-005-0832-x
8. C Tei LH Ling DO Hodge KR Bailey JK Oh RJ Rodeheffer AJ Tajik JB Seward 1995 New index of combined systolic and diastolic myocardial performance: A simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy J Cardiol 26 357-366 8558414 1:STN:280:BymC2czltFM%3D
9. C Tei KS Dujardin DO Hodge RA Kyle AJ Tajik JB Seward 1996 Doppler index combining systolic and diastolic myocardial performance: Clinical value in cardiac amyloidosis J Am Coll Cardiol 28 658-664 8772753 10.1016/ 0735-1097(96)00202-1 1:STN:280:BymA28fnsVE%3D
10. TC Yeo KS Dujardin C Tei DW Mahoney MD McGoon JB Seward 1998 Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension Am J Cardiol 81 1157-1161 9605059 10.1016/S0002-9149(98)00140-4 1:STN:280:DyaK1c3ms1Sqtw%3D%3D
11. KS Dujardin C Tei TC Yeo DO Hodge A Rossi JB Seward 1998 Prognostic value of a Doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy Am J Cardiol 82 1071-1076 9817484 10.1016/S0002-9149(98)00559-1 1:STN:280:DyaK1M%2Fjt1ChsA%3D%3D
12. C Bruch A Schmermund D Marin M Katz T Bartel J Schaar R Erbel 2000 Tei-index in patients with mild-to-moderate congestive heart failure Eur Heart J 21 1888-1895 11052862 10.1053/euhj.2000.2246 1:STN:280:DC%2BD3M%2FnvFensw%3D%3D
13. BW Eidem PW O'Leary C Tei JB Seward 2000 Usefulness of the myocardial performance index for assessing right ventricular function in congenital heart disease Am J Cardiol 86 654-658 10980218 10.1016/ S0002-9149(00)01047-X 1:STN:280:DC%2BD3M%2Fhtlyjsw%3D%3D
14. C Bruch A Schmermund N Dagres M Katz T Bartel R Erbel 2002 Tei-index in symptomatic patients with primary and secondary mitral regurgitation Int J Cardiovasc Imaging 18 101-110 12108905 10.1023/A:1014664418322
15. C Bruch A Schmermund N Dagres M Katz T Bartel R Erbel 2002 Severe aortic valve stenosis with preserved and reduced systolic left ventricular function: Diagnostic usefulness of the Tei index J Am Soc Echocardiogr 15 869-876 12221402 10.1067/mje.2002.120977
16. C Bruch A Schmermund N Dagres M Katz T Bartel R Erbel 2002 Tei-Index in coronary artery disease - validation in patients with overall cardiac and isolated diastolic dysfunction Z Kardiol 91 472-480 12219695 10.1007/ s00392-002-0808-0 1:STN:280:DC%2BD38vmtV2ntw%3D%3D
17. T Hole J Vegsundvag T Skjaerpe 2003 Estimation of left ventricular ejection fraction from Doppler derived myocardial performance index in patients with acute myocardial infarction: Agreement with echocardiographic and radionuclide measurements Echocardiography 20 231-236 12848660 10.1046/j.1540-8175.2003.03020.x
18. H Sasao R Noda T Hasegawa A Endo H Oimatsu T Takada 2004 Prognostic value of the Tei index combining systolic and diastolic myocardial performance in patients with acute myocardial infarction treated by successful primary angioplasty Heart Vessels 19 68-74 15042390 10.1007/ s00380-003-0735-7
19. S Koga S Ikeda K Matsunaga T Naito Y Miyahara K Taura S Kohno 2003 Influence of hemodialysis on echocardiographic Doppler indices of the left ventricle: Changes in parameters of systolic and diastolic function and Tei index Clin Nephrol 59 180-185 12653260 1:STN:280:DC%2BD3s7jvVWltw%3D%3D
20. LE Teichholz T Kreulen MV Herman R Gorlin 1976 Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence of absence of asynergy Am J Cardiol 37 7-11 1244736 10.1016/0002-9149(76)90491-4 1:STN:280:CSmD1crhs1A%3D
21. K Furukawa S Ikeda T Naito Y Miyahara T Iwasaki T Matsushita K Yakabe K Yamaguchi M Shikuwa Y Muraya S Kohno 2000 Cardiac function in dialysis patients evaluated by Doppler echocardiography and its relation to intradialytic hypotension: A new index combining systolic and diastolic function Clin Nephrol 53 18-24 10661478 1:STN:280:DC%2BD3c7isFWhsg%3D%3D
22. P Klimo JM Connors 1985 MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma Ann Intern Med 102 596-602 2580468 1:STN:280:BiqC2s3ptFw%3D
23. S Wakasugi AJ Fischman JW Babich RJ Callahan DR Elmaleh R Wilkinson HW Strauss 1993 Myocardial substrate utilization and left ventricular function in adriamycin cardiomyopathy J Nucl Med 34 1529-1535 8355075 1:CAS:528:DyaK2cXht1ylsLY%3D
24. S Wakasugi AJ Fischman JW Babich HT Aretz RJ Callahan M Nakaki R Wilkinson HW Strauss 1993 Metaiodobenzylguanidine: Evaluation of its potential as a tracer for monitoring doxorubicin cardiomyopathy J Nucl Med 34 1283-1286 8326385 1:STN:280:ByyA3Mnhs1c%3D
25. S Wakasugi A Wada Y Hasegawa S Nakano N Shibata 1992 Detection of abnormal cardiac adrenergic neuron activity in adriamycin-induced cardiomyopathy with iodine-125-metaiodobenzylguanidine J Nucl Med 33 208-214 1732442 1:CAS:528:DyaK38XhvVOksrY%3D
26. RD Olson PS Mushlin 1990 Doxorubicin cardiotoxicity: Analysis of prevailing hypotheses FASEB J 4 3076-3086 2210154 1:CAS:528:DyaK3MXhs12ktA%3D%3D
27. DD Von Hoff MW Layard P Basa HL Davis Jr AL Von Hoff M Rozencweig FM Muggia 1979 Risk factors for doxorubicininduced congestive heart failure Ann Intern Med 91 710-717 496103 1:STN:280:Bi%2BD2c%2FlvFE%3D
28. MR Bristow ME Billingham JW Mason JR Daniels 1978 Clinical spectrum of anthracycline antibiotic cardiotoxicity Cancer Treat Rep 62 873-879 667861 1:CAS:528:DyaE1cXkslSmt7g%3D
29. J Alexander N Dainiak HJ Berger L Goldman D Johnstone L Reduto T Duffy P Schwartz A Gottschalk BL Zaret 1979 Serial assessment of doxorubicin cardiotoxicity with quantitative radionuclide angiocardiography N Engl J Med 300 278-283 759880 1:STN:280:CSaD1MzosFE%3D
30. JH McKillop MR Bristow ML Goris ME Billingham K Bockemuehl 1983 Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity Am Heart J 106 1048-1056 6637763 10.1016/ 0002-8703(83)90651-8 1:STN:280:BiuD2cbgtl0%3D
31. MR Bristow JW Mason ME Billingham JR Daniels 1981 Dose-effect and structure-function relationships in doxorubicin cardiomyopathy Am Heart J 102 709-718 7282516 10.1016/0002-8703(81)90096-X 1:STN:280:Bi2D38%2FosFE%3D
32. LJ Steinherz T Graham R Hurwitz HM Sondheimer RG Schwartz EM Shaffer G Sandor L Benson R Williams 1992 Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Children's Cancer Study Group Pediatrics 89 942-949 1579408 1:STN:280:By2B2MzivFM%3D
33. Y Okada K Horikawa M Sano 1997 Echocardiographic evaluation of cardiotoxicity induced by anthracycline therapy (in Japanese) Gan To Kagaku Ryoho 24 585-589 9087292 1:STN:280:ByiB2c3is1E%3D
34. M Ishii T Tsutsumi W Himeno G Eto J Furui K Hashino Y Sugahara H Muta T Akagi A Ando H Eguchi H Kato 2000 Sequential evaluation of left ventricular myocardial performance in children after anthracycline therapy Am J Cardiol 86 1279-1281 11090811 10.1016/S0002-9149(00)01222-4 1:CAS:528:DC%2BD3cXot1yhsL0%3D
35. BW Eidem BG Sapp CR Suarez F Cetta 2001 Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children Am J Cardiol 87 1120-1122 11348617 10.1016/ S0002-9149(01)01476-X 1:STN:280:DC%2BD3MzntFajtw%3D%3D
36. L Elbl H Hrstkova V Chaloupka 2003 The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer Eur J Pediatr 162 690-696 12905011 10.1007/ s00431-003-1275-y 1:CAS:528:DC%2BD3sXntFSlsb8%3D